Sign in

CIK 0000730272 · Large accelerated filer

REPLIGEN CORP

Sign in to watch
Ticker
RGEN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
042729386
Phone
7814499560
Business address
41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM, MA, 02453
  1. 8-K Event Material agreement · New debt or obligation · Unregistered share sale
  2. 8-K Event Unregistered share sale · Other events
  3. 8-K Event Results of operations
  4. 8-K Event Acquisition or sale completed · Regulation FD disclosure
  5. 425 Deal Prospectus/Communication re Business Combination
  6. 8-K Event Executive or director change
  7. 425 Deal Prospectus/Communication re Business Combination
  8. 8-K Event Other events
  9. S-4/A Deal Registration Statement - Business Combination
  10. S-4 Deal Registration Statement - Business Combination
  11. 425 Deal Prospectus/Communication re Business Combination
  12. 8-K Event Results of operations
  13. 425 Deal Prospectus/Communication re Business Combination
  14. 425 Deal Prospectus/Communication re Business Combination
  15. 425 Deal Prospectus/Communication re Business Combination
  16. 8-K Event Material agreement · Results of operations · Regulation FD disclosure · Other events
  17. 8-K Event Shareholder vote results
  18. 8-K Event Results of operations
  19. 8-K Event Results of operations
  20. 8-K Event Executive or director change · Regulation FD disclosure

Page 1 of 13 · 260 filings